BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

103 related articles for article (PubMed ID: 19223532)

  • 1. Dysfunctional microvasculature as a consequence of shb gene inactivation causes impaired tumor growth.
    Funa NS; Kriz V; Zang G; Calounova G; Akerblom B; Mares J; Larsson E; Sun Y; Betsholtz C; Welsh M
    Cancer Res; 2009 Mar; 69(5):2141-8. PubMed ID: 19223532
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Aberrant association between vascular endothelial growth factor receptor-2 and VE-cadherin in response to vascular endothelial growth factor-a in Shb-deficient lung endothelial cells.
    Zang G; Christoffersson G; Tian G; Harun-Or-Rashid M; Vågesjö E; Phillipson M; Barg S; Tengholm A; Welsh M
    Cell Signal; 2013 Jan; 25(1):85-92. PubMed ID: 23000345
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Shb promotes blood vessel formation in embryoid bodies by augmenting vascular endothelial growth factor receptor-2 and platelet-derived growth factor receptor-beta signaling.
    Rolny C; Lu L; Agren N; Nilsson I; Roe C; Webb GC; Welsh M
    Exp Cell Res; 2005 Aug; 308(2):381-93. PubMed ID: 15919073
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Shb null allele is inherited with a transmission ratio distortion and causes reduced viability in utero.
    Kriz V; Mares J; Wentzel P; Funa NS; Calounova G; Zhang XQ; Forsberg-Nilsson K; Forsberg M; Welsh M
    Dev Dyn; 2007 Sep; 236(9):2485-92. PubMed ID: 17676633
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Role of the Src homology 2 domain-containing protein Shb in murine brain endothelial cell proliferation and differentiation.
    Lu L; Holmqvist K; Cross M; Welsh M
    Cell Growth Differ; 2002 Mar; 13(3):141-8. PubMed ID: 11959815
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Hydrodynamics-based gene delivery of naked DNA encoding fetal liver kinase-1 gene effectively suppresses the growth of pre-existing tumors.
    Yazawa H; Murakami T; Li HM; Back T; Kurosaka K; Suzuki Y; Shorts L; Akiyama Y; Maruyama K; Parsoneault E; Wiltrout RH; Watanabe M
    Cancer Gene Ther; 2006 Nov; 13(11):993-1001. PubMed ID: 16763608
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Vascular adaptation to a dysfunctional endothelium as a consequence of Shb deficiency.
    Christoffersson G; Zang G; Zhuang ZW; Vågesjö E; Simons M; Phillipson M; Welsh M
    Angiogenesis; 2012 Sep; 15(3):469-80. PubMed ID: 22562363
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Heterogeneity among RIP-Tag2 insulinomas allows vascular endothelial growth factor-A independent tumor expansion as revealed by studies in Shb mutant mice: implications for tumor angiogenesis.
    Åkerblom B; Zang G; Zhuang ZW; Calounova G; Simons M; Welsh M
    Mol Oncol; 2012 Jun; 6(3):333-46. PubMed ID: 22336752
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Vascular dysfunction and increased metastasis of B16F10 melanomas in Shb deficient mice as compared with their wild type counterparts.
    Zang G; Gustafsson K; Jamalpour M; Hong J; Genové G; Welsh M
    BMC Cancer; 2015 Apr; 15():234. PubMed ID: 25885274
    [TBL] [Abstract][Full Text] [Related]  

  • 10. (-)-Epigallocatechin gallate suppresses the growth of human hepatocellular carcinoma cells by inhibiting activation of the vascular endothelial growth factor-vascular endothelial growth factor receptor axis.
    Shirakami Y; Shimizu M; Adachi S; Sakai H; Nakagawa T; Yasuda Y; Tsurumi H; Hara Y; Moriwaki H
    Cancer Sci; 2009 Oct; 100(10):1957-62. PubMed ID: 19558547
    [TBL] [Abstract][Full Text] [Related]  

  • 11. VEGFR-1 and -2 regulate inflammation, myocardial angiogenesis, and arteriosclerosis in chronically rejecting cardiac allografts.
    Raisky O; Nykänen AI; Krebs R; Hollmén M; Keränen MA; Tikkanen JM; Sihvola R; Alhonen L; Salven P; Wu Y; Hicklin DJ; Alitalo K; Koskinen PK; Lemström KB
    Arterioscler Thromb Vasc Biol; 2007 Apr; 27(4):819-25. PubMed ID: 17290032
    [TBL] [Abstract][Full Text] [Related]  

  • 12. The role of the adapter protein SHB in embryonic stem cell differentiation into the pancreatic beta-cell and endothelial lineages.
    Saldeen J; Agren N; Akerblom B; Lu L; Adem B; Sedek L; Kriz V
    Methods Mol Biol; 2006; 330():353-72. PubMed ID: 16846036
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Angiogenesis: the VE-cadherin switch.
    Wallez Y; Vilgrain I; Huber P
    Trends Cardiovasc Med; 2006 Feb; 16(2):55-9. PubMed ID: 16473763
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Bone marrow-derived EP3-expressing stromal cells enhance tumor-associated angiogenesis and tumor growth.
    Ogawa Y; Suzuki T; Oikawa A; Hosono K; Kubo H; Amano H; Ito Y; Kitasato H; Hayashi I; Kato T; Sugimoto Y; Narumiya S; Watanabe M; Majima M
    Biochem Biophys Res Commun; 2009 May; 382(4):720-5. PubMed ID: 19318087
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Shb gene knockdown increases the susceptibility of SVR endothelial tumor cells to apoptotic stimuli in vitro and in vivo.
    Funa NS; Reddy K; Bhandarkar S; Kurenova EV; Yang L; Cance WG; Welsh M; Arbiser JL
    J Invest Dermatol; 2008 Mar; 128(3):710-6. PubMed ID: 17914455
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Mouse Breast Carcinoma Monocytic/Macrophagic Myeloid-Derived Suppressor Cell Infiltration as a Consequence of Endothelial Dysfunction in
    He Q; Jamalpour M; Bergquist E; Anderson RL; Gustafsson K; Welsh M
    Int J Mol Sci; 2021 Oct; 22(21):. PubMed ID: 34768912
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Impaired glucose homeostasis in Shb-/- mice.
    Akerblom B; Barg S; Calounova G; Mokhtari D; Jansson L; Welsh M
    J Endocrinol; 2009 Nov; 203(2):271-9. PubMed ID: 19696098
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Increased Hsp70 expression attenuates cytokine-induced cell death in islets of Langerhans from Shb knockout mice.
    Mokhtari D; Kerblom B; Mehmeti I; Wang X; Funa NS; Olerud J; Lenzen S; Welsh N; Welsh M
    Biochem Biophys Res Commun; 2009 Sep; 387(3):553-7. PubMed ID: 19615333
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Chemotherapy enhances metastasis formation via VEGFR-1-expressing endothelial cells.
    Daenen LG; Roodhart JM; van Amersfoort M; Dehnad M; Roessingh W; Ulfman LH; Derksen PW; Voest EE
    Cancer Res; 2011 Nov; 71(22):6976-85. PubMed ID: 21975929
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Decursin and decursinol angelate inhibit VEGF-induced angiogenesis via suppression of the VEGFR-2-signaling pathway.
    Jung MH; Lee SH; Ahn EM; Lee YM
    Carcinogenesis; 2009 Apr; 30(4):655-61. PubMed ID: 19228635
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 6.